Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TORSEMIDE, USP, with a corresponding US DMF Number 24549.
Remarkably, this DMF maintains an Active status since its submission on December 22, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 07, 2015, and payment made on July 29, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II